ASBP Aspire Biopharma Holdings, Inc.
Company Analysis
Latest News
Aspire Biopharma Holdings Files New Investor Presentation
Aspire Biopharma Holdings, Inc. filed a Form 8-K to announce the distribution of a new investor presentation, dated August 19, 2026. Key Details Filing...
Aspire BioPharma's Losses Shrink But Revenue Stays Tiny — Can a $7 Stock Justify the Optimism?
Shares jumped as investors digested second-quarter results showing Aspire BioPharma's cash burn is slowing dramatically, even as the company generates almost...
🟢 Aspire BioPharma is trading 7.31% up today after reporting narrower second-quarter losses
Aspire BioPharma is trading at $7.63 (+7.31%) after reporting second-quarter results with a narrower net loss. - Second-quarter sales were $63,104, while net...
🔴 Aspire BioPharma is trading 5.9% down today — no clear company-specific catalyst identified
Aspire BioPharma is trading 5.9% down at $7.16, with no clear company-specific catalyst identified for the August 12, 2026 decline. - On August 10, the...
🔴 Aspire BioPharma is trading 5.26% down in pre-market — no clear company-specific catalyst identified
Aspire BioPharma is trading 5.26% down at $7.21 after no clear company-specific overnight catalyst was identified. - The latest major announcement was the...
🔴 Aspire BioPharma is trading 5.52% down today in pre-market with no clear company-specific catalyst identified
Aspire BioPharma is trading 5.52% down at $7.36 in pre-market, with no clear overnight negative company-specific catalyst identified. - It closed at $7.79 on...
Aspire BioPharma, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 12, 2026
Aspire BioPharma enters its Q2 2026 earnings report with minimal formal coverage, though historical run-rates suggest a consensus revenue of approximately...
🔴 Aspire BioPharma is trading 6.29% down today in after-hours trading; no catalyst confirmed
Aspire BioPharma is trading at $7.30, down 6.29%, with no separate after-hours catalyst confirmed. - Regular-session close was $7.79, following a 0.78%...
🔴 Aspire BioPharma is trading 5% down today — no separate catalyst confirmed
Aspire BioPharma is trading 5% down now at $7.33; no separate catalyst explaining the decline has been confirmed. - On August 10, 2026, the company announced...
🟢 Aspire BioPharma is trading 10.20% up today amid biotech M&A optimism
Aspire BioPharma is trading $7.78 (+10.20%) as stronger biotech-sector sentiment appears linked to broader M&A optimism, though company-specific causation...
🟢 Aspire BioPharma is trading 6.03% up today amid renewed biotech M&A speculation
Aspire BioPharma is trading 6.03% up now at $7.70, with the move appearing primarily linked to stronger biotech sentiment. - The sector ETF is up 2.09% during...
🟢 Aspire BioPharma is trading 5.5% up today on broader biotech sector rally
Aspire BioPharma is trading 5.5% up today at $7.43, rebounding after yesterday’s profit-taking pullback. • The move aligns with a broader biotech rally and...
🔴 Aspire BioPharma is trading 5.5% down today on profit taking after a recent surge
Aspire BioPharma is trading 5.5% down at $6.83 today as the stock pulls back following a sharp multi-day rally. • The decline appears to be driven by...
🟢 Aspire BioPharma is trading 12.4% up today amid a broad market rally
Aspire BioPharma is trading 12.4% up at $7.33 amid a broad market rally and improving risk appetite. • The move appears aligned with major U.S. indexes, which...
🟢 Aspire BioPharma is trading 6.6% up today amid broader risk-on market sentiment
Aspire BioPharma is trading at $6.95 (+6.60%) today, with the move appearing consistent with broader risk-on market sentiment as major U.S. indexes trade...
🔴 Aspire BioPharma is trading 5.4% down today on profit-taking after a recent 20% rebound
Aspire BioPharma is trading 5.4% down at $6.36 following yesterday’s sharp rebound, with no new company-specific news driving today’s move. • The decline...
Aspire BioPharma Bounces 11% After Brutal Selloff, but Can Bargain Hunters Sustain a Stock This Thin?
Shares of Aspire BioPharma (ASBP) snapped back 11.4% to $6.25 on July 30, recouping roughly half of the prior session's punishing 22.6% plunge — a move driven...
🟢 Aspire BioPharma is trading 11.4% up today on a technical bounce and bargain-hunting
Aspire BioPharma is trading 11.4% higher at $6.25, staging a recovery after a sharp 22.6% drop to $5.61 on July 29, 2026. • The move appears driven by a...
🟢 Aspire BioPharma is trading 5.2% up today on a technical bounce after yesterday's sharp drop
Aspire BioPharma is trading 5.2% up at $5.90 in pre-market, extending a technical rebound after yesterday’s steep 22.6% drop to $5.61. • Market participants...
🟢 Aspire BioPharma is trading 12.3% up today on bargain-hunting and thin liquidity after a steep selloff
Aspire BioPharma is trading at $6.30 (12.3% up) in after-hours activity as the stock sees a technical rebound following a significant regular-session...